Glycomacropeptide for Management of Insulin Resistance and Liver Metabolic Perturbations.
Sauvé MF, Feldman F, Koudoufio M, Ould-Chikh NE, Ahmarani L, Sane A, N'Timbane T, El-Jalbout R, Patey N, Spahis S, Stintzi A, Delvin E, Levy E.
Sauvé MF, et al. Among authors: el jalbout r.
Biomedicines. 2021 Sep 2;9(9):1140. doi: 10.3390/biomedicines9091140.
Biomedicines. 2021.
PMID: 34572325
Free PMC article.